Urteste S.A. (WSE: URT)

Poland flag Poland · Delayed Price · Currency is PLN
83.20
-0.80 (-0.95%)
Nov 20, 2024, 4:49 PM CET
-5.45%
Market Cap 117.28M
Revenue (ttm) n/a
Net Income (ttm) -4.28M
Shares Out 1.41M
EPS (ttm) -3.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 848
Open 84.40
Previous Close 84.00
Day's Range 83.20 - 90.00
52-Week Range 79.80 - 112.50
Beta 0.14
Analysts n/a
Price Target n/a
Earnings Date Nov 28, 2024

About Urteste

Urteste S.A. engages in the research and development of diagnostic tests for cancers. It offers diagnostic tests for pancreas, prostate, kidney, colon, liver, biliary tract, stomach, lung, oesophagus, ovary, endometrium, blood, breast, and nervous system cancer. The company was incorporated in 2021 and is based in Gdansk, Poland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 20
Stock Exchange Warsaw Stock Exchange
Ticker Symbol URT
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.